ARTICLE | Company News
Mylan sales and marketing update
March 5, 2012 8:00 AM UTC
Mylan launched a generic version of escitalopram to treat major depressive disorder (MDD) and acute general anxiety disorder (GAD). Forest Laboratories Inc. (NYSE:FRX, New York, N.Y.) markets escital...